Gemin X's Acquisition

Gemin X was acquired by Cephalon on June 16, 2011.

Gemin X Pharmaceuticals is dedicated to the discovery, development and commercialization of novel, targeted cancer therapeutics to improve the lives of patients.…

Articles about Gemin X's Acquisition: